【透景生命:江西透景、脉示生物取得2项医疗器械注册证】透景生命公告,控股子公司江西透景、脉示生物于近日分别取得江西省药品监督管理局、上海市药品监督管理局颁发的医疗器械注册证,涉及全自动流式荧光发光免疫分析仪和四项抗癫痫药物浓度测定试剂盒,注册证有效期分别至2031年09月03日、2031年09月16日。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.